Spots Global Cancer Trial Database for Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Official Title: A Randomized Phase II-III Multicenter Trial of Docetaxel Plus Cisplatin and Docetaxel Plus 5-FU Versus Cisplatin Plus 5-FU in 1st Line Treatment of Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck.
Study ID: NCT00401323
Study Description
Brief Summary: The purpose of the study is to compare time to progression and overall survival after treatment with Taxotere plus cisplatin versus cisplatin plus 5-FU (PF treatment group) in the first line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
sanofi-aventis US, Bridgewater, New Jersey, United States
Sanofi-Aventis, Buenos Aires, , Argentina
sanofi-aventis, Australia, Macquarie Park, New South Wales, Australia
Sanofi-Aventis, Vienna, , Austria
sanofi-aventis, Belgium, Diegem, , Belgium
Sanofi-Aventis, Rio de Janeiro, , Brazil
sanofi-aventis Canada, Laval, Quebec, Canada
sanofi-aventis, France, Paris, , France
sanofi-aventis Germany, Berlin, , Germany
sanofi-aventis Greece, Athens, , Greece
Sanofi-Aventis, Basse-Terre, , Guadeloupe
Sanofi-Aventis Hungaria, Budapest, , Hungary
sanofi-aventis Israel, Natanya, , Israel
sanofi-aventis Italy, Milano, , Italy
Sanofi-Aventis, Moscow, , Russian Federation
Sanofi-Aventis, Saint-Denis, , Réunion
sanofi-aventis South Africa, Midrand, , South Africa
Sanofi-Aventis, Madrid, , Spain
sanofi-aventis Switzerland, Geneva, , Switzerland
Sanofi-Aventis, Montevideo, , Uruguay
Contact Details
Name: Clinical Sciences & Operations
Affiliation: Sanofi
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
